Xiaomeng Jia
Overview
Explore the profile of Xiaomeng Jia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun L, Jia X, Wang K, Li M
Breast
. 2024 Nov;
78:103830.
PMID: 39500221
Breast cancer has become the most prevalent malignant tumor worldwide and remains one of the leading causes of cancer-related mortality among women globally. The prognosis for patients with metastatic breast...
2.
Jia X, Gao X, Zhang S, Inman J, Hong Y, Singh A, et al.
bioRxiv
. 2024 Oct;
PMID: 39464009
The inherent helical structure of DNA dictates that a replisome must rotate relative to DNA during replication, presenting inevitable topological challenges to replication. However, little is known about how the...
3.
Jia X, Inman J, Singh A, Patel S, Wang M
bioRxiv
. 2024 Oct;
PMID: 39416053
Replication of DNA requires the parental DNA to be unwound to allow the genetic information to be faithfully duplicated by the replisome. While this function is usually shared by a...
4.
Jia X, Liu W, Ai Y, Cheung S, Hu W, Wang Y, et al.
Adv Mater
. 2024 Sep;
36(44):e2404071.
PMID: 39279582
Engineered hydrogel patches have shown promising therapeutic effects in the treatment of myocardial infarction (MI), especially anisotropic patches that mimic the characteristics of native myocardium have attracted widespread attention. However,...
5.
Jia X, Shen D, Deng J, Wang K, Wang X, Guo Y, et al.
Anal Chim Acta
. 2024 Jul;
1317:342916.
PMID: 39030013
Background: Protein misfolding and aggregation can lead to various diseases. Recent studies have shed light on the aggregated protein in breast cancer pathology, which suggests that it is crucial to...
6.
Jia X, Wang K, Zhuo Q, Zhao Z, Li M
Clin Breast Cancer
. 2024 Apr;
24(5):392-398.e3.
PMID: 38580572
Poly-ADP ribose polymerase inhibitor (PARPi) is approved for HER2-negative advanced breast cancer with BRCA1/2 mutation. In recent years, many studies have explored the application of PARPi in neoadjuvant therapy, but...
7.
Cheung S, Zhong Y, Wu L, Jia X, He M, Ai Y, et al.
J Ethnopharmacol
. 2024 Mar;
328:117976.
PMID: 38492794
Ethnopharmacological Relevance: Guhan Yangshengjing (GHYSJ) is an effective prescription for delaying progression of Alzheimer's disease (AD) based on the ancient Chinese medical classics excavated from Mawangdui Han Tomb. Comprising a...
8.
He M, Ai Y, Hu W, Jia X, Wu L, Ding M, et al.
Anal Chem
. 2023 Mar;
95(14):6130-6137.
PMID: 37002208
The localized surface plasmon resonance (LSPR) property, depending on the structure (morphology and assembly) of nanoparticles, is very sensitive to the environmental fluctuation. Retaining the colorimetric effect derived from the...
9.
Ai Y, He M, Sun H, Jia X, Wu L, Zhang X, et al.
Adv Mater
. 2023 Mar;
35(23):e2302335.
PMID: 36995655
High-entropy alloys nanoparticles (HEANPs) are receiving extensive attention due to their broad compositional tunability and unlimited potential in bioapplication. However, developing new methods to prepare ultra-small high-entropy alloy nanoparticles (US-HEANPs)...
10.
Lin L, Wang A, Jia X, Wang H, He Y, Mu Y, et al.
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1081520.
PMID: 36909319
Purpose: The hemoglobin glycation index (HGI) quantifies the mismatch between glycated hemoglobin A1c and average glycemia among individuals. Currently, it is unknown the potential role of HGI in exhaustively evaluating...